Pharmacoeconomic aspects related to the 13-valent pneumococcal conjugate vaccine: preliminary analysis of the data from the ASL of Viterbo
INTRODUCTION: Streptococcus pneumoniae is a pathogen of considerable importance to public health because it causes morbidity and mortality on the world population. It has more than 90 serotypes with different epidemiological characteristics and pathogenicity. Some categories of the population are pa...
Main Authors: | Silvia Dari, Flavia Verginelli, Silvia Aquilani |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2014-12-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/980 |
Similar Items
-
Pneumococcal Infection among Children before Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Cambodia
by: Paul Turner, et al.
Published: (2015-11-01) -
Experience with 13-valent conjugated pneumococcal vaccine in HIV-infected patients
by: A. V. Zhestkov, et al.
Published: (2020-12-01) -
Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children
by: Corinne Levy, et al.
Published: (2021-08-01) -
Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population
by: Deirdre A. Collins, et al.
Published: (2017-09-01) -
Impact of 10-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children up to two years of age in Brazil
by: Indianara Maria Grando, et al.
Published: (2015-02-01)